Subscribe to our latest updates, reports and upcoming events. Subscribe >
From To
Subscribe to our latest updates, reports and events.
SubscribeShowing 1 - 10 of 87
Sort by
News 08/10/2021
Following the publication of The Legal 500 UK 2022, we are proud to announce that the firm has once again achieved impressive rankings and recognition within the latest guide to leading law firms and lawyers.
News 06/10/2021
We are pleased to have strengthened our London team with the appointment of partner Simon Durkin, formerly at Weightmans.
News 08/07/2021
We are pleased to again report a record turnover of £264m, an increase of 11% on the previous year (£238m).
Article 13/05/2021
The COVID-19 pandemic has had an unprecedented impact on stakeholders in the UK and EU’s life sciences industry - from companies, to third parties, governments, regulators and insurers.
News 20/04/2021
We are pleased to announce that the publication of the 2021 edition of The Legal 500 Europe, Middle East and Africa has seen us build on our 2020 achievements.
Article 07/04/2021
In this Q&A, Ian Kimber, Emeritus Professor of Toxicology in the Faculty of Biology, Medicine and Health at the University of Manchester, provides an immunological perspective on current issues impacting upon the life sciences sector, ranging from recently approved cancer drugs to COVID-19 vaccines.
Report 30/03/2021
The vulnerabilities of the life science supply chain are at the forefront of everyone’s minds, but, behind the headlines, how is the pandemic affecting attitudes to risk?
Article 04/03/2021
2020 was a challenging year globally. However, the start of 2021 has welcomed the rapid roll out of the breakthrough COVID-19 vaccines in the UK, a ray of hope for a way out of the pandemic. Over 20 million people in the UK have already been given vaccine doses, with the hope that the majority of the UK adult population will be vaccinated by the end of 2021.
Article 19/02/2021
The outcome of two Canadian product class actions in 2020 signal hurdles claimants may face around the globe in 2021 in alleging adverse health effects in mass tort claims involving products for consumption such as medical cannabis, other pharmaceutical products and food.
Report 09/02/2021
This report examines the key features of the Directive of the European Parliament and of the European Council on representative actions for the protection of the collective interests of consumers and its wider impact on consumer-led litigation across Europe, including comparative insights into national class action mechanisms in the United Kingdom, Belgium, Denmark, France, Portugal, Spain and Ireland.
